How can we, humans, look at our relationship to nature differently? In season three of Going Wild, on top of stories about animals, we invite you to journey through the entire ecological web â from the tiniest of life forms to apex predators â alongside the scientists, activists and adventurers who study it. Wildlife biologist and host Dr. Rae Wynn-Grant has been studying wild animals in their natural habitats all over the world for years. Our award-winning podcast takes you inside the hidde ...
…
continue reading
Inhalt bereitgestellt von Jon Chee. Alle Podcast-Inhalte, einschlieĂlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Jon Chee oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschĂŒtztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Player FM - Podcast-App
Gehen Sie mit der App Player FM offline!
Gehen Sie mit der App Player FM offline!
𧏠David Li - Meliora Therapeutics - Part 2 | From Finance to Biotech Entrepreneurship | Building Solid Teams & Navigating Market Dynamics | Lessons in Early-Stage Startups
MP3•Episode-Home
Manage episode 426981165 series 3461709
Inhalt bereitgestellt von Jon Chee. Alle Podcast-Inhalte, einschlieĂlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Jon Chee oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschĂŒtztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code âTBSPâ on https://www.excedr.com/rewards.
Part 2 of 4.
My guest for this weekâs episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.
Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding.
David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. His multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.
Join us this week and hear about:
- Davidâs pivot from finance roles at Goldman Sachs and KKR to early-stage entrepreneurship in the Life Sciences
- The challenges of moving from private equity to startups
- Aligning personal values with career choices, building solid teams, and the role of luck in success.
- His time at Benchling as Head of Commercial Operations and at Everest Detection as the Chief Business Officer
Please enjoy my conversation with David Li.
Timestamps:
00:28 Intro
01:56 Working in Finance at Goldman Sachs and KKR, rethinking how to make an impact
04:59 Switching to early-stage entrepreneurship, prioritizing team strength and market dynamics
06:25 Experience at Benchling, data software issues & digitization in the life sciences
11:09 The role of luck in success, figuring out what you can and canât control
14:02 Challenges and lessons working in startups, maintaining internal conviction
17:43 Contemplating a new role after Benchling, joining Everest Detection
20:25 The different skills David learned while building a team, getting wins early on
23:56 Outro
Find Our Guest, David Li, at these links:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes:
Topics Mentioned:
Goldman Sachs https://www.goldmansachs.com/
Benchling https://www.benchling.com/
Everest Detection https://everestdetection.com/
Salesforce https://www.salesforce.com/
Digitization of Life Sciences https://www.deloitte.com/global/en/Industries/life-sciences-health-care/perspectives/gx-digital-transformation-in-life-sciences.html
Go-to-Market Motion/Strategy https://www.wrike.com/go-to-market-guide/faq/what-is-go-to-market-motion/
Marketing & Sales Strategies & Tools https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs
Structuring Sales Comp at a Startup https://www.vouris.com/blog/sales-compensation-plan-for-startups
Content Marketing https://mailchimp.com/marketing-glossary/content-marketing/
Product Marketing vs. Growth Marketing https://userpilot.com/blog/product-marketing-vs-growth-marketing/
People Mentioned:
Bryan Slingerland https://www.linkedin.com/in/brian-slingerland-a7a14b35/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
76 Episoden
MP3•Episode-Home
Manage episode 426981165 series 3461709
Inhalt bereitgestellt von Jon Chee. Alle Podcast-Inhalte, einschlieĂlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Jon Chee oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschĂŒtztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code âTBSPâ on https://www.excedr.com/rewards.
Part 2 of 4.
My guest for this weekâs episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.
Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding.
David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. His multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.
Join us this week and hear about:
- Davidâs pivot from finance roles at Goldman Sachs and KKR to early-stage entrepreneurship in the Life Sciences
- The challenges of moving from private equity to startups
- Aligning personal values with career choices, building solid teams, and the role of luck in success.
- His time at Benchling as Head of Commercial Operations and at Everest Detection as the Chief Business Officer
Please enjoy my conversation with David Li.
Timestamps:
00:28 Intro
01:56 Working in Finance at Goldman Sachs and KKR, rethinking how to make an impact
04:59 Switching to early-stage entrepreneurship, prioritizing team strength and market dynamics
06:25 Experience at Benchling, data software issues & digitization in the life sciences
11:09 The role of luck in success, figuring out what you can and canât control
14:02 Challenges and lessons working in startups, maintaining internal conviction
17:43 Contemplating a new role after Benchling, joining Everest Detection
20:25 The different skills David learned while building a team, getting wins early on
23:56 Outro
Find Our Guest, David Li, at these links:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes:
Topics Mentioned:
Goldman Sachs https://www.goldmansachs.com/
Benchling https://www.benchling.com/
Everest Detection https://everestdetection.com/
Salesforce https://www.salesforce.com/
Digitization of Life Sciences https://www.deloitte.com/global/en/Industries/life-sciences-health-care/perspectives/gx-digital-transformation-in-life-sciences.html
Go-to-Market Motion/Strategy https://www.wrike.com/go-to-market-guide/faq/what-is-go-to-market-motion/
Marketing & Sales Strategies & Tools https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs
Structuring Sales Comp at a Startup https://www.vouris.com/blog/sales-compensation-plan-for-startups
Content Marketing https://mailchimp.com/marketing-glossary/content-marketing/
Product Marketing vs. Growth Marketing https://userpilot.com/blog/product-marketing-vs-growth-marketing/
People Mentioned:
Bryan Slingerland https://www.linkedin.com/in/brian-slingerland-a7a14b35/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
76 Episoden
Alle episoder
×Willkommen auf Player FM!
Player FM scannt gerade das Web nach Podcasts mit hoher QualitĂ€t, die du genieĂen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos gerĂ€teĂŒbergreifend zu synchronisieren.